Original language | English (US) |
---|---|
Pages (from-to) | 66-69 |
Number of pages | 4 |
Journal | JAAD Case Reports |
Volume | 30 |
DOIs | |
State | Published - Dec 2022 |
Bibliographical note
Funding Information:We would like to thank Daniel D. Miller, MD, at the University of Minnesota, for helping with the histopathologic images for this patient. Funding sources: None.
Keywords
- ICI
- drug response
- durvalumab
- immune checkpoint inhibitor
- immune related adverse event
- irAE
- medical dermatology
- oncology
- progressing
- purpura
- rapidly
- retiform
- retiform purpura
- thrombotic occlusive vasculopathy